EVH Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
652.5M
+31.5%
496.2M
+5.9%
468.7M
-2.3%
479.5M
+7.9%
444.3M
Cost of Revenue
571.7M
+38.6%
412.5M
+11.0%
371.5M
-2.2%
379.8M
+10.4%
343.9M
Gross Profit
80.8M
-3.5%
83.8M
-13.9%
97.3M
-2.5%
99.8M
-0.6%
100.4M
Operating Expenses
90.4M
-4.2%
94.4M
-81.9%
520.4M
+426.2%
98.9M
-2.6%
101.6M
R&D
0
0
0
0
0
SG&A
68.8M
-5.5%
72.8M
+0.2%
72.7M
-6.4%
77.6M
+3.2%
75.2M
Operating Income
-9561000
+9.8%
-10599000
+97.5%
-423098000
-47853.7%
886.0K
+175.7%
-1171000
EBITDA
13.1M
+10.2%
11.9M
-45.2%
21.7M
-21.6%
27.7M
+19.0%
23.3M
Net Income
-28364000
-6.5%
-26632000
+93.8%
-429131000
-1956.8%
-20864000
-4.9%
-19897000
EPS (Basic)
$-0.25
-4.2%
$-0.24
+93.8%
$-3.85
-1504.2%
$-0.24
+45.5%
$-0.44
EPS (Diluted)
$-0.25
-4.2%
$-0.24
+93.8%
$-3.85
-1504.2%
$-0.24
+45.5%
$-0.44
Shares (Diluted)
112.5M
+0.6%
111.9M
+0.3%
111.6M
-2.2%
114.1M
-1.6%
115.9M
Evolent Health (EVH) โ€” Financials